Laurent Fonquernie

Laurent Fonquernie

Auto-generated profile, based on publicly available information

Laurent Fonquernie

Hôpital Saint-Antoine, Paris, France

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2004 in HIV Medicine
Verified
Journal Article
Closed access
PDF file
LFL Fonquernie
L Fonquernie
LSL Serfaty
L Serfaty
ACA Charrois
A Charrois
DWD Wendum
D Wendum
BLB Lefebvre
B Lefebvre
JMJl Meynard
Jl Meynard

23 August 2017 in Journal of Medical Internet Research
Verified
Journal Article
Open access
SFSarah F Feldman
Sarah F Feldman
NLNathanael Lapidus
Nathanael Lapidus
JCJacques Cosnes
Jacques Cosnes
ETEmmanuel Tiret
Emmanuel Tiret
LFLaurent Fonquernie
Laurent Fonquernie
GHGilles Hejblum
Gilles Hejblum
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

1 May 2006 in Medecine Et Maladies Infectieuses
Verified
Journal Article
Closed access
LFL. Fonquernie
L. Fonquernie
RDR. Dray-Spira
R. Dray-Spira
EBE. Bamogo
E. Bamogo
FLF. Lert
F. Lert
PGP.-M. Girard
P.-M. Girard

1 December 2007 in Medecine Et Maladies Infectieuses
Verified
Journal Article
Open access
LFL. Fonquernie
L. Fonquernie
SCS. Clozel
S. Clozel
JVJ.-P. Vincensini
J.-P. Vincensini
FBF. Boccara
F. Boccara
BRB. Rousselle
B. Rousselle
PGP.-M. Girard
P.-M. Girard
The Saint-Antoine Orchestra Program aims at improving the clinical management of HIV-infected patients through access to care, prevention and early diagnosis of comorbidities. The program was initiated in December 2004 on the whole database. The following topics were concerned: cardiovascular risk factors, gynecological follow-up, anti-HBV vaccinal coverage, sexuality and prevention of STIs, therapeutic adherence and counsels to travelers. The program included several actions: diffusion of information to patients, development of a computerized chart (alert pop-ups), individualized prescription advice and recommendations for specialist referral. The program was applied to 1959 patients whose initial characteristics were: mean age: 43+/-10 years; ratio M/W: 1466/493; European origin: 69%; sub-Saharan: 19%; mean duration of HIV infection: 9.3+/-6 years; naïve of antiretrovirals: 14%; mean CD4+count: 494+/-277/mm(3); HIV viral load inferior to 50 cp/ml: 62%. Among 1347 patients for whom cardiovascular risk factors were completely informed, 42% had two or more factors. In particular, 31% of them were smokers, 7% had an arterial pressure superior to 140/90 mmHg and 11% had LDL-cholesterolemia superior to 4.1 mmol/l. Among 1448 untreated patients, 70% were initially considered as adherent. Half of the concerned women had neither cervical smear nor mammography up to date. Among 67% patients with an informed complete HBV serology, 27% were seronegative among which 310 (86%) were eligible for the vaccine. Problems of sexual difficulties or prevention were initially discussed for 11% of patients. Among them, 14% had a problem of prevention and 148 (66%) recognized sexual difficulties. The initiation of the Saint-Antoine Orchestra program has provided a unique opportunity to assess and improve the prevention and management of comorbidities in HIV patients. Also, this program aimed to improve professional practices.

1 March 2006 in Transactions of the Royal Society of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
LFLaurent Fonquernie
Laurent Fonquernie
SESerge P. Eholié
Serge P. Eholié
FDFlorence Damond
Florence Damond
KLKarine Lacombe
Karine Lacombe
PGPierre-Marie Girard
Pierre-Marie Girard
We report the case of an HIV-2-infected patient with severe immunosupression despite undetectable plasma HIV-2 RNA. This immunovirological discordance was due to failure of the viral load assay and infection by an unknown HIV-2 subtype. Treatment was probably suboptimal, leading to the selection of several resistance mutations and treatment failure.

5 August 2021 in Clinical and Experimental Neuroimmunology
Verified
Journal Article
Closed access
PDF file
NFNathalie Forgeard
Nathalie Forgeard
EJEdouard Januel
Edouard Januel
ABAnne Blancher
Anne Blancher
LFLaurent Fonquernie
Laurent Fonquernie
AGAgnès Gautheret‐Dejean
Agnès Gautheret‐Dejean
MMMarie‐Caroline Meyohas
Marie‐Caroline Meyohas